In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis

Maxime Donadieu1, Nathanael J Lee1,2, María I Gaitán1

  • 1Translational Neuroradiology Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States.

Elife
|April 21, 2023
PubMed

Insights

Magnetic resonance imaging (MRI) can effectively detect and characterize remyelination in a marmoset model of multiple sclerosis (MS). This breakthrough aids in evaluating potential treatments for this debilitating neurological disease.

Area of Science:

  • Neuroscience
  • Radiology
  • Immunology

Background:

  • Remyelination is essential for recovery from inflammatory demyelination in multiple sclerosis (MS).
  • In vivo investigation of remyelination using magnetic resonance imaging (MRI) in MS is challenging due to difficulties in obtaining serial, short-interval scans.

Purpose of the Study:

  • To investigate the sensitivity and characterization capabilities of MRI for detecting remyelination.
  • To assess remyelination in the experimental autoimmune encephalomyelitis (EAE) marmoset model, a relevant model for MS.

Main Methods:

  • Utilized multisequence 7 Tesla (7 T) MRI to follow six common marmosets with EAE.
  • Assessed 31 focal lesions for remyelination status using MRI signal intensity.
  • Correlated MRI findings with subsequent histopathological analysis of the lesions.

Main Results:

  • Spontaneous remyelination was observed in four out of six marmosets, occurring in 45% of the lesions.
  • MRI demonstrated high statistical sensitivity (100%) and specificity (90%) in detecting remyelination.
  • The study confirmed the prevalence of spontaneous remyelination in the marmoset EAE model.

Conclusions:

  • In vivo MRI is a sensitive and specific tool for detecting and characterizing remyelination in the marmoset EAE model.
  • This finding has significant implications for preclinical testing of pro-remyelinating therapies for multiple sclerosis.